Drug Approval | October 04, 2021
Biocon launches Everolimus tablets in the US
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise
The investment will increase SpeeDx internal capacity to scale up manufacturing
The company is the Clinical Research Organisation of Caplin Point Laboratories
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
These modules will act as a guide to doctors and health care workers to deal with post-Covid-19 issues
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
Godrej and Boyce and Isgec Engineering have confirmed receiving the orders
Subscribe To Our Newsletter & Stay Updated
